Biodexa Pharmaceuticals BDRX
NASDAQ BDRX
$0.42 +0.03 (+8.98%)
As of: Oct 21, 2026 · 3:59 PM EDT

Biodexa Pharmaceuticals (BDRX) Cash from Operations (2013 - 2014)

Updated

Biodexa Pharmaceuticals (BDRX) posted Cash from Operations of -$7.37 million for the year ended Dec 31, 2025, compared with -$15.67 million a year earlier.

Analysis

Biodexa Pharmaceuticals (BDRX) Cash from Operations (2013 - 2014) Analysis & Trends

Since the year ended Dec 31, 2013, Biodexa Pharmaceuticals has reported Cash from Operations for 13 years.

  • The figure for the year ended Dec 31, 2025 stands as the highest annual Cash from Operations since the year ended Dec 31, 2013.
  • Business Quant data shows BDRX's Cash from Operations at -$15.67 million in the year ended Dec 31, 2024, -$8.49 million in the year ended Dec 31, 2023, -$8.72 million in the year ended Dec 31, 2022 and -$8.27 million in the year ended Dec 31, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 10.69 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 8.62 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 3.44 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 5.37 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 5.88 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 2.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 4.00 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 3.57 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 835.00 Mn
10 Biodexa Pharmaceuticals 4,123.69 -23.40 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2014 -8.64 Mn
Dec 31, 2013 -7.18 Mn
API Access

Biodexa Pharmaceuticals Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BDRX&period=max&api_key=YOUR_API_KEY